KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.

Disease Markers
Qi ZhangChangjiang Qin

Abstract

Kinesin family member 20A (KIF20A) has been recently reported to be upregulated and associated with increased invasiveness and metastasis in several malignancies. However, the role of KIF20A in colorectal cancer (CRC) is still unclear. This study is aimed at investigating the potential roles of KIF20A in the development of CRC. The results of bioinformatics analysis, immunohistochemical staining, and Western blot analysis showed that KIF20A was overexpressed in CRC tissues compared with adjacent normal tissues. High expression of KIF20A in CRC tissues was associated with depth of invasion, lymphatic node metastasis, distant metastasis, and TNM stage. Moreover, the Kaplan-Meier survival analysis showed that CRC patients with high KIF20A expression had poor prognoses. Cox regression analysis revealed that KIF20A was an independent prognostic factor in patients with CRC. Further studies suggested that knockdown of KIF20A was able to reduce cell proliferation and migration by inhibiting the JAK/STAT3 pathway. Taken together, we propose that KIF20A plays a critical role in the tumorigenesis and tumor progression of colorectal cancer and could represent a potential therapeutic target for CRC.

References

Mar 4, 1998·Current Opinion in Cell Biology·N HirokawaY Okada
Nov 4, 2000·The EMBO Journal·E HillF A Barr
Mar 18, 2006·Genome Biology·Esther GraudensSandrine Imbeaud
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Jul 21, 2007·International Journal of Cancer. Journal International Du Cancer·Dong Hyuk KiSun Young Rha
Jan 4, 2008·Molecular Cancer Research : MCR·Jacob Sabates-BellverGiancarlo Marra
Mar 6, 2008·Neoplasia : an International Journal for Oncology Research·Hua XiongJing-Yuan Fang
Jul 16, 2008·Physiological Reviews·Nobutaka Hirokawa, Yasuko Noda
Sep 24, 2009·Nature Reviews. Molecular Cell Biology·Nobutaka HirokawaShinsuke Niwa
Nov 8, 2011·The American Journal of Pathology·Isabelle GasnereauJoëlle Sobczak-Thépot
Nov 29, 2011·Molecular Carcinogenesis·Martha L SlatteryRoger K Wolff
Aug 3, 2012·Acta Dermato-venereologica·Junji YamashitaHironobu Ihn
Sep 6, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemUNKNOWN ESMO Guidelines Working Group
Oct 11, 2014·Science·Phuong A NguyenTimothy J Mitchison
Oct 25, 2014·Nature Reviews. Cancer·Hua YuRichard Jove
Dec 17, 2014·Neoplasia : an International Journal for Oncology Research·Keisuke TaniuchiToshiji Saibara
May 9, 2015·The Journal of Surgical Research·Daniela StangelJörg Kleeff
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 2, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Dec 31, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qian LiangJie Hong
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 29, 2018·European Journal of Pharmacology·Guanghong XiuZe Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
transfections
Protein Assay
transfection
scraping

Software Mentioned

Excel
GraphPad Prism
SPSS
FireBrowse

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.